Permissionless Science at Scale Bridging Researchers and Crypto Liquidity
Hear how Genesys Labs plans to bridge scientists and crypto builders, why “coin-to-company” is the future, and how DeFi can unlock faster and permissionless research.
In this episode of DeSci Pilled, Ryan talks with Rahim and Andrew, the co-founders of Genesys Labs, about how decentralized science and crypto can change the way we fund and build biotech.
They share their journeys from biotech, psychedelics research, and citizen science into the DeSci world, and how an experiment on Pump Science proved that trading fees can fund real scientific studies.
You’ll hear how Genesys Labs plans to bridge scientists and crypto builders, why “coin-to-company” is the future, and how DeFi can unlock faster and permissionless research. Rahim and Andrew also discuss the role of AI in generating new scientific ideas, the rise of virtual biotech companies, and why Genesys Labs is building an incubator to help launch the next wave of on-chain science projects.
Watch the episode.